MPWT
MLNT

MassMutual Private Wealth & Trust’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30
Closed – – 831
2020
Q1 		$0 Buy
+30
New +$16 ﹤0.01% 832

MassMutual Private Wealth & Trust's MLNT Position: Q2 2020 in Review

MassMutual Private Wealth & Trust sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q2 2020, closing a stake of 30 shares.

MassMutual Private Wealth & Trust first reported a position in MLNT in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 0 funds tracked by Wall St. Rank hold MLNT as of Q2 2020.

  • MassMutual Private Wealth & Trust reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 30 Melinta Therapeutics, Inc. Common Stock shares in Q2 2020.
  • MassMutual Private Wealth & Trust first reported a position in Melinta Therapeutics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Melinta Therapeutics, Inc. Common Stock position peaked at $0 in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q2 2020.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2020, filed 13 Aug 2020.